NS · Pharmaceuticals

Medicamen Biotech Ltd (MEDICAMEQ)

Pharmaceuticals & Biotechnology

Medicamen Biotech Ltd (MEDICAMEQ) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $3.29B, P/E ratio is 34.73, net margin is 6.3%, dividend yield is 0.41%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MEDICAMEQ

Market cap

$3.29B

P/E ratio

34.73

Net margin

6.3%

Dividend yield

0.41%

Medicamen Biotech Ltd (MEDICAMEQ) — FAQ

What is Medicamen Biotech Ltd's market cap?

Medicamen Biotech Ltd (MEDICAMEQ) has a reported market cap of $3.29B (data as of 2026-07-10).

What is MEDICAMEQ's P/E ratio?

The price-to-earnings (P/E) ratio for Medicamen Biotech Ltd (MEDICAMEQ) is 34.73 (data as of 2026-07-10).

Does Medicamen Biotech Ltd pay a dividend?

Medicamen Biotech Ltd (MEDICAMEQ) shows a reported dividend yield of 0.41%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Medicamen Biotech Ltd in?

Medicamen Biotech Ltd (MEDICAMEQ) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is MEDICAMEQ listed on?

MEDICAMEQ is listed on NS.

What is Medicamen Biotech Ltd's net margin?

Medicamen Biotech Ltd (MEDICAMEQ) reports a net margin of 6.3% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)